NCT05271084View on ClinicalTrials.gov

Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

February 25, 2022

Study Completion Date

June 8, 2022

Conditions
Major Depressive Disorder
Interventions
DRUG

Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg

Selective serotonin reuptake inhibitor (SSRI) + phosphodiesterase inhibitor with anti-inflammatory properties

DRUG

Citalopram (tablet) 20 mg + Placebo (tablet)

Selective serotonin reuptake inhibitor (SSRI) + placebo

Trial Locations (1)

44001

Hawler Psychiatric Hospital and Private Clinic, Erbil

All Listed Sponsors
lead

Hawler Medical University

OTHER

NCT05271084 - Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter